Factors that Contribute to the QTc Interval Prolongation in DR-TB Patients on STR Regimen
Keywords:QTc interval prolongation, STR regimen, Drug Resistance Tuberculosis (DR-TB)
Introduction: QTc interval prolongation is one of the adverse drug reaction of several drugs used in DR-TB
patients treated with STR regimen. Drug-induced QTc prolongation can predispose patient to develop lifethreatening arrhythmia, increasing hospital length of stay and mortality. This study aims to determine factors
that contribute to QTc prolongation in DR-TB patients on STR regimen.
Methods. This was an observational retrospective study using medical records of DR-TB patients who
received STR regimen from August 2017 to March 2019 in tertiary hospital DR Soetomo, Surabaya,
Indonesia. QTc interval was calculated by Fredericia formula. The influence of risk factors (age, body
weight (BW), Body Mass Index (BMI), gender, comorbid, potassium, sodium and QTc baseline) with QTc
prolongation was analyzed using multiple regression. The relationship between Moxifloxacin dosage and
QTc was analyzed using Chi-Square test.
Results Out of the 113 DR-TB patients who received the STR therapy regimen, 98 patients were eligible for
this study. They consist of 62 (%) male; 36 (%) female. Thirty-five (35,7%) of them had Diabetes Mellitus
as a comorbid disease. The mean age of the patients was 44±11 years, with the mean of BMI was 20.20±
3.73. Potassium and Sodium levels at the baseline were 4.192 ± 0.58 and 138.05 ± 4.562 respectively. The
QTc baseline before receiving STR regimen was 431.9±30,617ms. Patients received a dose of moxifloxacin
400 mg (5.1%) , 600 mg (59,2%), and 800 mg (35,7%) according to body weight. There were no correlation
between age, BW, gender, comorbid, and sodium baseline with QTc. There were correlation between
potassium (p=0,001), BMI (p=0,006) and QTc baseline (p <0,001) with QTc.
Conclusion QTc baseline and potassium level are factors that contribute to the prolongation of the QTc
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions